HEMATOLOGY - myeloproliferative RBC disorders: polycythemia vera Flashcards
EXAM 2 content
what is polycythemia?
EXCESSIVE red cell production –> increase blood viscosity (thickness) & volume (hypervolemia)
what are the types of polycythemia? what is each about?
relative polycythemia: from hemoconcentration
- associated with dehydration –> fluid replacement & treat underlying problem
absolute polycythemia: primary & secondary
- primary = polycythemia vera = slow growing cancer, bone marrow makes too many RBCs
- secondary = physiologic response due to hypoxia that causes erythropoietin secretion – seen w ppl at higher altitudes > 10k ft, smokers w incr CO2, COPD, & heart failure
what is the pathophysiology of primary absolute polycythemia (aka polycythemia vera, PV)?
95% of ppl have the mutation of tyrosine kinase, Janus Kinase 2 (JAK2) –> erythropoietin receptor is constantly active no matter the level of erythropoietin –> stimulated bone marrow to produce RBCs–> uncontrolled proliferation of RBCs + increase levels of WBCs & platelets (–> leukocytosis + thrombocytosis)
what are the risk factors of PV?
its RARE
- b/w 60-80 yo
- males are 2x more likely to develop PV
- more common in whites of eastern european jewish ancestry
what are the clinical manifestations of PV?
- aquagenic pruritus: intense & painful itching with heat
- hypervolemia & hyperviscosity –> hypertension –> red color of face, hands, feet, ears & mucus membranes
- headache
- drowsy
- delirium
- mania
- psychotic depression
- chorea
- visual disturbances
- enlarged spleen –> abdominal pain & discomfort
what lab data do we use to determine if someone has PV? what are the normal ranges for WBC & plates?
major diagnostic criteria
- high hgb
- high hct
- high RBC mass
erythrocytes appear normal BUT anisocytosis (variation of sizes of RBCs is high) present
moderate increase in WBC & plates
- norm WBC = 5k-10k / uL
- norm plate = 150k-400k / uL
what are the diagnostic procedures to determine if someone has polycythemia vera?
bone marrow biopsy with cytogenetic & molecular studies for mutations in JAK2
- presence of a JAK2 mutation = confirming diagnosis of PV
what is the disease trajectory of polycythemia vera?
survival of 10-15 years
without treatment –> 50% will die within 18 months bc of thrombosis or hemorrhage
- in a hypercoagulable state –> clogging + occlusion of blood vessels
- tissue ischemia & tissue death (infarction) – stroke
- hemorrhage: bc of inadequate plate function
risk of acute myeloid leukemia (AML, another cancer)
how do we treat PV?
goals =
- reduce RBC proliferation & BV
- control symptoms
- prevent clogging & clotting of blood vessels
how do we treat low risk patients?
phlebotomy of removing 300-500 mL at a time –> decreases erythrocytes & BV
- every few days until hct reaches acceptable level
- cont PRN q2-3 months
lose-dose aspirin to prevent clotting
what medication can we use to treat polycythemia vera? what does it do?
MYELOSUPPRESSANTS –>
- for high risk pts
- slows the production of myeloid cells in bone marrow
what drugs are meylosuppressants? what does each one do?
HYDROXYUREA: most common, lower risk for leukemia & thrombosis
INTERFERON (IFN) ALPHA: used when other forms of treatment have failed
what is one more thing we can do to decrease RBC? side effects?
radiation therapy with RADIOACTIVE PHOSPHORUS (32P) – slows RBC production
- effects last up to 18 months
- side effects: anemia, leukopenia, thrombocytopenia
- higher risk of acute leukemia